| Company Name: | DNAVEC Corporation |
| Established: | September 5, 2003 |
| Headquarters: | Techno Park Oho, 6 Ohkubo, Tsukuba, Ibaraki 300-2611 Japan |
| Laboratories: | Tsukuba Laboratory(at Headquarters) |
| Capital: | ¥2,085,150,000 |
| Board of Directors: | President and CEO | Mamoru Hasegawa |
| Managing Director | Tsugumine Shu |
| Director | Yohei Tanida |
| Director | Makoto Inoue |
| Senior Auditor | Kunikatsu Shirahata |
| Auditor | Shiro Toba |
| Auditor | Kiyomi Kindaichi |
| Number of Employees: | 24 |
| Business Activities: |
- Gene Medicines
- Antibody Medicines
- Cell Therapy and Regenerative Medicines
- Other Bio-Business
|
| Related Company: |
Beijing B & M Biotech Co., Ltd. (PRC) |
